PortfoliosLab logo

BriaCell Therapeutics Corp. (BCT.TO)

Equity · Currency in CAD · Last updated Mar 24, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of CA$10,000 invested in BriaCell Therapeutics Corp. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$307 for a total return of roughly -96.93%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%NovemberDecember2023FebruaryMarch
-96.93%
102.41%
BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BCT.TO

BriaCell Therapeutics Corp.

Return

BriaCell Therapeutics Corp. had a return of 57.80% year-to-date (YTD) and -17.46% in the last 12 months. Over the past 10 years, BriaCell Therapeutics Corp. had an annualized return of -14.82%, while the S&P 500 had an annualized return of 6.51%, indicating that BriaCell Therapeutics Corp. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-5.96%-3.20%
Year-To-Date57.80%2.84%
6 months14.51%5.40%
1 year-17.46%-13.73%
5 years (annualized)-25.08%4.45%
10 years (annualized)-14.82%6.51%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202368.81%-3.21%
2022-22.93%-5.48%-2.43%-18.51%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BriaCell Therapeutics Corp. Sharpe ratio is -0.17. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.50NovemberDecember2023FebruaryMarch
-0.17
-0.55
BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)

Dividend History


BriaCell Therapeutics Corp. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-98.44%
-19.10%
BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the BriaCell Therapeutics Corp.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BriaCell Therapeutics Corp. is 99.40%, recorded on May 19, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.4%May 2, 20111942May 19, 2021
-83.33%Dec 4, 200696Apr 24, 2009218Oct 15, 2010314
-51.72%Oct 18, 201020Nov 15, 2010103Apr 29, 2011123
-9.09%Oct 20, 20061Oct 20, 20067Dec 1, 20068

Volatility Chart

Current BriaCell Therapeutics Corp. volatility is 64.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%NovemberDecember2023FebruaryMarch
64.83%
19.59%
BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)